MicroBase Technology

MicroBase Technology EBITDA Growth YoY

The Year-over-Year EBITDA Growth of MicroBase Technology (3184.TWO) as of Oct 31, 2026 is -13.77 %. In the previous year, Year-over-Year EBITDA Growth was 146.88 % — a change of -109.37% (lower).

EBITDA Growth YoY

-13.77 %

YoY

-109.37%

Last updated:

Year-over-Year EBITDA Growth of MicroBase Technology is 2025 -13.77 % . Year-over-Year EBITDA Growth of MicroBase Technology was 2024 146.88 % . It decreases by -109.37% lower compared to the previous year.

The MicroBase Technology EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2016
-31.00 TWD
Jan 1, 2017
14.47 TWD
Jan 1, 2018
91.64 TWD
Jan 1, 2021
59.41 TWD
Jan 1, 2022
55.37 TWD
Jan 1, 2023
257.47 TWD
Jan 1, 2024
146.88 TWD
Jan 1, 2025
-13.77 TWD
The MicroBase Technology EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
-13.77 %-109.37%
146.88 %-42.95%
257.47 %+364.95%
55.37 %-6.80%
59.41 %-35.16%
91.64 %+533.36%
14.47 %-146.67%
-31.00 %-401.28%
10.29 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MicroBase Technology Stock analysis

What does MicroBase Technology do? MicroBase Technology Corp, listed on the Taiwan Stock Exchange under ticker 3184.TWO, is a health care company headquartered in Taoyuan, Taiwan. The company has 48 employees and completed its initial public offering on April 18, 2013. MicroBase Technology Corp engages in the production, planning, and maintenance of medical equipment. The company's product portfolio includes the Inkjet Printer Nozzle Plate, Microneedle Patch, Aerosol Generator Head, Nebulizer, and Soft Mist Inhaler, among others. These products are distributed both domestically within Taiwan and internationally to overseas markets. The company operates within the health care sector, focusing on medical equipment solutions. MicroBase Technology Corp maintains a website at https://microbasetech.com/ for further information. The company's operations are centered around the development and distribution of specialized medical devices, with an emphasis on both local and global market reach. As a publicly traded entity, it provides transparency through its financial disclosures and corporate governance practices. The firm's activities are primarily conducted in Taoyuan, Taiwan, reflecting its regional operational base. MicroBase Technology Corp's business model involves the manufacturing and maintenance of medical equipment, targeting both domestic and international customers through its product offerings. MicroBase Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MicroBase Technology stock

Year-over-Year EBITDA Growth of MicroBase Technology is -13.77 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth MicroBase Technology since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's MicroBase Technology historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — MicroBase Technology

All Key Metrics — MicroBase Technology